Role of vitamin E and D3 supplementation in Intra-Cytoplasmic Sperm Injection outcomes of women with polycystic ovarian syndrome: A double blinded randomized placebo-controlled trial

Clinical Nutrition ESPEN

Volumn 18, Issue , 2017, Pages 23-30

  Fatemi, Farnaz ^a   Mohammadzadeh, Afsaneh ^a   Sadeghi, Mohammad Reza ^a   Akhondi, Mohammad Mehdi ^a   Mohammadmoradi, Shayan ^b   Kamali, Koorosh ^a   Lackpour, Nicknam ^a   Jouhari, Sheida ^a   Zafadoust, Simin ^a   Mokhtar, Sara ^a   Giahi, Ladan ^a  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Female infertility; ICSI; Oxidative stress; Polycystic ovarian syndrome; Vitamin D3; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; COLECALCIFEROL; MALONALDEHYDE;

ADULT; ANTIOXIDANT ASSAY; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; EMBRYO DEVELOPMENT; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FOLLOW UP; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OOCYTE DEVELOPMENT; OOCYTE RETRIEVAL; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; OXIDATIVE STRESS; PRACTICE GUIDELINE; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ADOLESCENT; DIETARY SUPPLEMENT; MALE; PREGNANCY; PREGNANCY OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFERTILITY, FEMALE; MALE; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME; VITAMIN E; YOUNG ADULT;

EID: 85010905734     PISSN: 24054577     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnesp.2017.01.002     Document Type: Article

References (31)

1. [1] Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H.F., Futterweit, W., et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:2 (2009), 456–488.
2. [2] Goodarzi, M.O., Dumesic, D.A., Chazenbalk, G., Azziz, R., Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7:4 (2011), 219–231.
3. [3] Ndefo, U.A., Eaton, A., Green, M.R., Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches. Pharm Ther 38:6 (2013), 336–355.
4. [4] Norman, R.J., Dewailly, D., Legro, R.S., Hickey, T.E., Polycystic ovary syndrome. Lancet 370:9588 (2007), 685–697.
5. [5] Murri, M., Luque-Ramírez, M., Insenser, M., Ojeda-Ojeda, M., Escobar-Morreale, H.F., Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 19:3 (2013), 268–288.
6. [6] Hyderali, B.N., Mala, K., Oxidative stress and cardiovascular complications in polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol 191 (2015), 15–22.
7. [7] Antioxidants for female subfertility [Internet], 2013, John Wiley & Sons, Ltd.
8. [8] Sabuncu, T., Vural, H., Harma, M., Harma, M., Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem 34:5 (2001), 407–413.
9. [9] Cicek, N., Eryilmaz, O., Sarikaya, E., Gulerman, C., Genc, Y., Vitamin E effect on controlled ovarian stimulation of unexplained infertile women. J Assist Reprod Genet 29:4 (2012), 325–328.
10. [10] Traber, M.G., Atkinson, J., Vitamin E, antioxidant and nothing more. Free Radic Biol Med 43:1 (2007), 4–15.
11. [11] Cavalcante, I.G.d.M., Silva, A.S., Costa, M.J.C., Persuhn, D.C., Issa, C.I., Freire, T.L.d.L., et al. Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency: vitamin D3 megadose reduces inflammatory markers. Exp Gerontol 66 (2015), 10–16.
12. [12] Chen, Y., Zhang, J., Ge, X., Du, J., Deb, D.K., Li, Y.C., Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB Kinase β protein. J Biol Chem 288:27 (2013), 19450–19458.
13. [13] Ozkan, S., Jindal, S., Greenseid, K., Shu, J., Zeitlian, G., Hickmon, C., et al. Replete vitamin D stores predict reproductive success following in vitro fertilization. Fertil Steril 94:4 (2010), 1314–1319.
14. [14] Rotterdam, E., Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:1 (2003), 19–25.
15. [15] Pasqualotto, E.B., Agarwal, A., Sharma, R.K., Izzo, V.M., Pinotti, J.A., Joshi, N.J., et al. Effect of oxidative stress in follicular fluid on the outcome of assisted reproductive procedures. Fertil Steril 81:4 (2004), 973–976.
16. [16] Mokhtar, S., Sadeghi, M.R., Akhondi, M.M., Zafardoust, S., Badenush, B., Fatemi, F., et al. ART outcomes in GnRH antagonist protocol (flexible) and long GnRH agonist protocol during early follicular phase in patients with polycystic ovary syndrome: a randomized clinical trial. J Reprod Infertil 16:3 (2015), 148–154.
17. [17] Zafardoust, S., Jeddi-Tehrani, M., Akhondi, M.M., Sadeghi, M.R., Kamali, K., Mokhtar, S., et al. Effect of administration of single dose GnRH agonist in luteal phase on outcome of ICSI-ET cycles in women with previous history of IVF/ICSI failure: a randomized controlled trial. J Reprod Infertil 16:2 (2015), 96–101.
18. [18] Satoh, K., Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 90 (1978), 37–43.
19. [19] Kazemi, A., Sharifi, F., Jafari, N., Mousavinas, N., High prevalence of vitamin D deficiency among pregnant women and their newborns in an Iranian population. J Women's Health 18:6 (2009), 835–839.
20. [20] Rudick, B., Ingles, S.A., Stanczyk, F., Chung, K., Paulson, R., Bendikson, K., The role of vitamin D levels on IVF outcomes in donor-recipient cycles. Fertil Steril, 95(4), 2012, S8.
21. [21] Aleyasin, A., Hosseini, M.A., Mahdavi, A., Safdarian, L., Fallahi, P., Mohajeri, M.R., et al. Predictive value of the level of vitamin D in follicular fluid on the outcome of assisted reproductive technology. Eur J Obstet Gynecol Reprod Biol 159:1 (2011), 132–137.
22. [22] Tarcin, O., Yavuz, D.G., Ozben, B., Telli, A., Ogunc, A.V., Yuksel, M., et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 94:10 (2009), 4023–4030.
23. [23] Rajaei, S., Mirahmadian, M., Jeddi-Tehrani, M., Tavakoli, M., Zonoobi, M., Dabbagh, A., et al. Effect of 1,25(OH)2 vitamin D3 on cytokine production by endometrial cells of women with repeated implantation failure. Gynecol Endocrinol 28:11 (2012), 906–911.
24. [24] Johnson, L.E., DeLuca, H.F., Vitamin D receptor null mutant mice fed high levels of calcium are fertile. J Nutr 131:6 (2001), 1787–1791.
25. [25] Kinuta, K., Tanaka, H., Moriwake, T., Aya, K., Kato, S., Seino, Y., Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology 141:4 (2000), 1317–1324.
26. [26] Rudick, B., Ingles, S., Chung, K., Stanczyk, F., Paulson, R., Bendikson, K., Characterizing the influence of vitamin D levels on IVF outcomes. Hum Reprod 27:11 (2012), 3321–3327.
27. [27] Viganò, P., Lattuada, D., Mangioni, S., Ermellino, L., Vignali, M., Caporizzo, E., et al. Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. J Mol Endocrinol 36:3 (2006), 415–424.
28. [28] Evans, K.N., Nguyen, L., Chan, J., Innes, B.A., Bulmer, J.N., Kilby, M.D., et al. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol Reprod 75:6 (2006), 816–822.
29. [29] Yeh, J., Bowman, M.J., Browne, R.W., Chen, N., Reproductive aging results in a reconfigured ovarian antioxidant defense profile in rats. Fertil Steril 84 (2003), 1109–1113.
30. [30] Agarwal, A., Gupta, S., Sekhon, L., Shah, R., Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications. Antioxid Redox Signal 10:8 (2008), 1375–1403.
31. [31] Aurrekoetxea, I., Ruiz-Sanz, J.I., del Agua, A.R., Navarro, R., Hernández, M.L., Matorras, R., et al. Serum oxidizability and antioxidant status in patients undergoing in vitro fertilization. Fertil Steril 94:4 (2010), 1279–1286.